A New Jersey appeals court has overturned a pair of $9 million verdicts against Hoffmann-La Roche Inc. in suits by Accutane users who claimed they developed ulcerative colitis after taking the drug.
The Appellate Division on July 22 ruled that two evidentiary rulings made by the trial judge were sufficiently prejudicial to warrant a new trial.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
